Featured Posts
City Journal
The FTC Jettisons Economics—and Law
The Federal Trade Commission is stepping up its pursuit of its new favorite bogeyman: Pharmacy Benefit Managers. Two months ago, the FTC issued an …
HeartLand Daily News
FDA Hid COVID Shot Side Effects—Congressional Report
Heartland Daily News cited CEI on COVID public health concerns Joel Zinberg, M.D., senior fellow at the Competitive Enterprise Institute and director of the Public…
The Wall Street Journal
The FTC Goes Evidence-Free
Through three years of Lina Khan’s leadership, the Federal Trade Commission has suffered an unprecedented streak of high-profile court defeats. That’s because the agency regularly makes…
Search Posts
Letters
CEI Joins Coalition Opposing March-In over Drug Prices
Dear Secretary Becerra, On behalf of millions of Americans across the country, we urge you to ignore calls and petitions asking you to deliberately twist…
Letters
CEI Joins Coalition Urging Congress to End Ban on DC Marijuana Sales
Dear Members of Congress, As you and your colleagues in Congress continue to finalize funding levels and bill language in the FY22 appropriations bill, the…
Letters
CEI Joins NTU-Led Coalition Warns of BBB’s Impact on Drug Competition
Dear Senators and Representatives: On behalf of the undersigned organizations — taxpayer, consumer, and free market advocates from across the country — we write with…
Letters
CEI Joins ATR Led Drug Price Control Coalition Letter
Dear Member of Congress: We write in opposition to the Democrat plan to impose price controls, a 95 percent excise tax, and inflation penalties on…
National Review
Innovators to the Rescue
Thirty years ago, I spoke at a conference on xenotransplantation — the transplantation of organs, cells, or tissues between species — at Columbia…
Blog
Democrats’ Drug Price Control Bill Is a Prescription for Disaster
Last Thursday, House Democrats reintroduced a bill from the last Congress, which they claim will protect Medicare from excessive prescription drug prices. Sadly, it…
